Adage Capital Management, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

Filing Manager
Adage Capital Management, L.P.
Reporting Manager
Adage Capital Management, L.P.
Security
Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol
ALGS
Shares outstanding
3,464,819 shares
Disclosed Ownership
325,000 shares
Ownership
9.4%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2025, 09:32:46 UTC
Date of event
31 Dec 2024
Next filing
12 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Adage Capital Management, L.P. disclosed 9.4% ownership in Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS) on 31 Dec 2024."

Quick Takeaways

  • Adage Capital Management, L.P. filed SCHEDULE 13G/A for Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS).
  • Disclosed ownership: 9.4%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Feb 2025, 09:32.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 9.4% 325,000 0 325,000 /s/ Robert Atchinson Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Robert Atchinson 9.4% 325,000 0 325,000 /s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 9.4% 325,000 0 325,000 /s/ Phillip Gross Phillip Gross, individually

Sponsored